Hollywood Tomorrow
Film

A24 Previews Elizabeth Holmes Doc From Nathan Fielder and Lance Oppenheim

The distributor held an unannounced Telluride screening for "You Can See Everything," a new docudrama exploring the disgraced Theranos founder.

By Maya Chen · September 7, 2026 · 1 min read

Published by Hollywood Tomorrow

Film illustration for A24 Previews Elizabeth Holmes Doc From Nathan Fielder and Lance Oppenheim
Film illustration for A24 Previews Elizabeth Holmes Doc From Nathan Fielder and Lance Oppenheim

A24 staged an unannounced festival screening for *You Can See Everything*, a new docudrama centered on convicted Theranos founder Elizabeth Holmes, at the Telluride Film Festival.

The project marks a high-profile collaboration between director Lance Oppenheim and producer Nathan Fielder. The film blends traditional non-fiction filmmaking with dramatic elements to track the downfall of the former Silicon Valley executive.

Initial critical and audience impressions emerged quickly following the Colorado premiere, giving the industry its first glimpse at the closely held production, according to reporting from The Hollywood Reporter.

Holmes remains a frequent subject of screen adaptations following her 2022 conviction on multiple counts of wire fraud and conspiracy, which resulted in an 11-year prison sentence. Her story previously anchored Alex Gibney's HBO documentary *The Inventor* and Hulu's Emmy-winning scripted miniseries *The Dropout*.

## Stylistic Divergence

The Telluride showcase indicates A24's intent to position the feature within the fall awards and festival corridor rather than routing it strictly as a commercial true-crime release.

By pairing Oppenheim, known for stylized non-fiction portraits such as *Some Kind of Heaven*, with Fielder's brand of reality-bending comedy and structural experimentation, the project represents an unconventional take on well-trodden subject matter.

A24 has not yet announced an official commercial release date or rollout strategy for the title.

Reported from the originating source.

Share this story

Keep up with the industry

Join the morning memo for a short daily brief.